Drugs / Rivaroxoban
last change Jun 2024 re-read 2 minutes ago

Rivaroxoban

Developed for
myocardial infarction
Investigated by
Chief Scientist Office of the Scottish Government · University of Edinburgh

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05419583 Nov 2022 → Jun 2024 myocardial infarction University of Edinburgh Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Rivaroxoban ClinicalTrials.gov intervention name — accepted as the source's own label NCT05419583